Promise and Peril of Pretomanid-Rifamycin Regimens for Drug-susceptible Tuberculosis

被引：0
|
作者：
Velasquez, Gustavo E. [1 ,2 ]
Nahid, Payam [1 ,3 ]
机构：
[1] UCSF Ctr TB, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Div HIV Infect Dis & Global Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷 / 07期
关键词：
BACTERICIDAL ACTIVITY; MOXIFLOXACIN; PYRAZINAMIDE; PA-824; TRIAL;
D O I：
10.1164/rccm.202212-2262ED
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：816 / 818
页数：4
相关论文
共 50 条
  • [1] A bedaquiline, pretomanid, moxifloxacin, and pyrazinamide regimen for drug-susceptible and drug-resistant tuberculosis
    Deng, Guofang
    Fu, Liang
    LANCET INFECTIOUS DISEASES, 2024, 24 (09): : 940 - 941
  • [2] New Regimens for Reducing the Duration of Treatment of Drug-Susceptible Pulmonary Tuberculosis
    Conde, Marcus B.
    Lapa e Silva, Jose R.
    DRUG DEVELOPMENT RESEARCH, 2011, 72 (06) : 501 - 508
  • [3] Linezolid for drug-susceptible tuberculosis
    Han, Jiyeon
    Yim, Jae-Joon
    LANCET INFECTIOUS DISEASES, 2019, 19 (05): : 468 - 469
  • [4] Drug-susceptible tuberculosis - Reply
    Friedman, DR
    Quinn, GC
    Kreiswirth, BN
    Perlman, DC
    Saloman, N
    Schluger, N
    Lutfey, M
    Berger, J
    Poltoratskaia, N
    Riley, LW
    JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04): : 1138 - 1139
  • [5] Treatment of Drug-Susceptible Tuberculosis
    Dela Cruz, Charles S.
    Lyons, Patrick G.
    Pasnick, Susan
    Weinstock, Tanya
    Nahid, Payam
    Wilson, Kevin C.
    Thomson, Carey C.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (11) : 2060 - 2063
  • [6] Linezolid for drug-susceptible tuberculosis
    Bilgin, Huseyin
    Tukenmez-Tigen, Elif
    LANCET INFECTIOUS DISEASES, 2019, 19 (04): : 357 - 357
  • [7] Social determinants of drug-susceptible and drug resistant tuberculosis
    Artiom, Jucov
    Evelina, Lesnic
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [8] A Review of Moxifloxacin for the Treatment of Drug-Susceptible Tuberculosis
    Naidoo, Anushka
    Naidoo, Kogieleum
    McIlleron, Helen
    Essack, Sabiha
    Padayatchi, Nesri
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (11): : 1369 - 1386
  • [9] The use of bedaquiline in regimens to treat drug-resistant and drug-susceptible tuberculosis: a perspective from tuberculosis-affected communities
    Mingote, Laia Ruiz
    Namutamba, Dorothy
    Apina, Francis
    Barnabas, Nomampondo
    Contreras, Carmen
    Elnour, Taharqa
    Frick, Mike Watson
    Lee, Cynthia
    Seaworth, Barbara
    Shelly, Debra
    Skipper, Natalie
    dos Santos Filho, Ezio Tavora
    LANCET, 2015, 385 (9966): : 477 - 479
  • [10] A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
    Marjorie Z. Imperial
    Payam Nahid
    Patrick P. J. Phillips
    Geraint R. Davies
    Katherine Fielding
    Debra Hanna
    David Hermann
    Robert S. Wallis
    John L. Johnson
    Christian Lienhardt
    Rada M. Savic
    Nature Medicine, 2018, 24 : 1708 - 1715
12345